Compare
Abbott Laboratories vs UFP Technologies (ABT vs UFPT)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and UFP Technologies (UFPT) +29.4%; so far this year the figures are -12.3% and +36.7%.
Abbott Laboratories is the larger company by market value, about 81.0 times the size of UFP Technologies.
On trailing earnings, ABT trades at 40.9 times and UFPT at 30.9 times.
Revenue grew +10.0% at ABT and +8.6% at UFPT over the last year.
ABT yields 2.29%. UFPT pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | UFPT | |
|---|---|---|
| Price | $109.93 | $303.47 |
| 1-day | -3.23% | +1.22% |
| YTD | -12.26% | +36.68% |
| 1 year | -11.73% | +29.42% |
| 3 years | +15.70% | +122.05% |
| Market cap | $190.4B | $2.4B |
| P/E | 40.9 | 30.9 |
| P/S | 3.95 | 3.62 |
| P/B | 3.73 | 4.84 |
| Revenue growth | +10.00% | +8.60% |
| EPS growth | -66.20% | +13.70% |
| Gross margin % | 56.9 | 28.9 |
| Net margin % | 9.7 | 11.8 |
| ROE % | 9.2 | 15.8 |
| Debt / equity | 0.61 | 0.20 |
| FCF yield % | 3.5 | 3.2 |
| Dividend yield % | 2.29 | — |
| Beta | 0.06 | 1.58 |
| RSI (14) | 58.5 | 53.9 |
| Technical rating |